Status: Recruiting
A Study of NT 201 in Adults With Moderate to Severe Platysma Prominence in Europe (PLATINUM EU)
The purpose of this study is to assess the safety and efficacy of NT 201 compared with placebo in participants with moderate to severe platysma prominence. The study will be conducted in two periods: Main Period (MP) and Open label Extension Period (OLEX).
Participants needed: 300
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Merz Aesthetics GmbHUpdated: Jun 12, 2026Locations: 26
Eligibility criteria
Presence of four (medial and lateral, left and right) platysmal bands assessed a... [+1]
Hypersensitivity or a history of allergic reaction to botulinum toxin of any ser... [+6]